NKF Clinical Meetings Present New Scientific Findings

New York, NY (June 10, 2005) - Interactive sessions, a stellar faculty, breakthrough science, new Fellows programs and increased attendance from many disciplines resulted in one of the most successful Spring Clinical Meetings held by the National Kidney Foundation, May 4-8, 2005 in Washington, DC.

For the first time, the NKF partnered with the American Board of Internal Medicine (ABIM) to offer meeting participants a special Nephrology Recertification course for ABIM credit. One of the requirements for nephrology recertification is the successful completion of five booklets. Participants completed one of the booklets in a full-day session. Drs. Gerald Appel, Roy Bloom, Michael Emmett and Paul Kimmel served as faculty for this very popular course, which will be back for the 2006 Spring Clinical Meetings.

Edmund Lewis, MD, presented new scientific findings as the Dr. Shaul Massry Lecturer. Dr. Lewis announced positive interim results from the Phase 2 Clinical Study for

KRX-101 (sulodexide gelcaps) for the Treatment of Diabetic Nephropathy. The findings for the efficacy of KRX-101 appear to be among the most exciting developments in treating diabetic nephropathy.

The Spring Clinical Meetings also celebrated the publication of the latest NKF-K/DOQI guidelines, Cardiovascular Disease in Dialysis Patients. Key highlights from the guidelines were presented at a standing-room-only session, chaired by Drs. William Henrich and Adeera Levin.

Save the dates for the NKF’s 2006 Spring Clinical Meetings, April 19-23, Chicago. Visit www.kidney.org for information about the 2006 meeting.